India’s Central Drugs Standard Control Organization (CDSCO) just rolled out a new Guidance Document for importing and registering drugs—both bulk and finished formulations, as of…
Biological Products Licenses and Approvals in India: Your Guide to the CDSCO Process by ACPL Group India – Regulatory Affairs Experts India has really carved
FSSAI has scrapped mandatory BIS certification for packaged drinking water and replaced it with a strict new testing regime from January 2026. Here’s what water bottlers must do now.
Importing medical devices into India isn’t simple—it’s tightly regulated by the Central Drugs Standard Control Organization, or CDSCO. The Central Licensing Authority (CLA), which is
India’s medical device market is booming. Demand keeps rising for new diagnostic and treatment tools, and global manufacturers have noticed—India’s now a key destination for
Innovation keeps industries moving forward, and organizations that put time and money into research and development are right at the center of India’s push for
PESO, or the Petroleum and Explosives Safety Organisation, stands as India’s central authority for keeping hazardous substances in check. They’re in charge of making sure
CPCB has moved from rule-making to enforcement on plastic EPR—Registered Environment Auditors, customs blocks, and crore-level penalties are now live. Here’s what producers and importers must do.
Regulatory compliance has always been the backbone of a trustworthy supply chain, but a recent directive from the Central Drugs Standard Control Organization (CDSCO) highlights
CDSCO Bans 16 Fixed Dose Combinations: What Pharma Companies Need to Know Effective June 11, 2026, the Central Drugs Standard Control Organisation (CDSCO) has banned
